Regulatory science and pharmaceuticals

Babatunde D, Pollock AM, Ocan M, et al. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus. JRSM Open. 2024;15:20542704241232814. download

Brhlikova P, Walker R, Fothergill-Misbah N, Pollock AM. Bridging the treatment gap. World Neurology. 2023;38:14–5. download

Brhlikova P, Mehta A, McGettigan P, Pollock AM, Roderick P, Farooqui HH. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics. Journal of Pharmaceutical Policy and Practice. 2023;16:139. download

Thakur DS, Reddy P. India’s alarming ‘fixed dose combination’ problem. The Hindu. 2023. download

Brhlikova P, Persaud N, Osorio-de-Castro CGS, Pollock AM. Essential medicines lists are for high income countries too. BMJ 2023;382:e076783. download

Brhlikova P, Deivanayagam TA, Babar Z-U-D, Osorio-de-Castro CGS, Caetano R, Pollock AM. Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation. Journal of Pharmaceutical Policy and Practice 2023;16:88. download

Green A, Lyus R, Ocan M, Pollock AM. Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis. J R Soc Med 2023:01410768231181263. download

Baldeh A-O, Millard C, Pollock AM, Brhlikova P. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda. Journal of Pharmaceutical Policy and Practice 2023;16:18. download

Roderick P. Regulating new drugs in India needs to be improved. The Lancet Regional Health – Southeast Asia 2023;10. download

Sevcikova P, Pollock AM. India jeopardizing ‘pharmacy of the world’ status. Asia Times. 15 November 2022.

Pollock AM, Sevcikova P. Unregulated ‘innovation’: India’s medicine problem. The Conversation. 14 November 2022.

Mehta A, Brhlikova P, McGettigan P, Pollock AM, Roderick P, Farooqui, HH. Systemic antibiotic sales and WHO recommendations, India. Bulletin of the World Health Organization Online First: 22 August 2022. download

Pollock AM, Ocan M, Sevcikova P. East African countries should prioritise their essential medicines for drug registration. The Conversation 18 Nov 2020.

Lyus R, Pollock AM, Ocan M, Brhlikova P. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018. Bulletin of the WHO 2020;98(8):530–538. download

Brhlikova P, Maigetter K, Murison J, Agaba AG, Tusiimire J, Pollock AM. Registration and local production of essential medicines in Uganda. Journal of Pharmaceutical Policy and Practice 2020;13(1):31. download

Rees C, Brhlikova P, Pollock AM. Will HPV vaccination prevent cervical cancer? JRSM 2020. download

Allan C, Joyce TJ, Pollock AM. Europe’s new device regulations fail to protect the public. BMJ. 2018 Oct 10;363:k4205. download

Millard C. Essential medicines are missing from Maharashtra’s pharmacies. The Swaddle, 18 Mar 2018.

Evans V, Roderick P, Pollock AM. Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India. BMJ Global Health. 2018;3:e000263. download

McGettigan P, Roderick P, Kadam A, Pollock AM. Threats to global antimicrobial resistance control; centrally approved and unapproved antibiotic formulations sold in India. British Journal of Clinical Pharmacology. 2018 download

Millard C, Kadam A, Mahajan R, Pollock AM, Brhlikova P. Availability of brands of six essential medicines in 124 pharmacies in Maharashtra. Journal of Global Health. 2018;8(1). download

McGettigan P, Pollock AM. India not doing enough to stop sale of unapproved antibiotics. Asia Times. 14 October 2017.

Pollock AM, McGettigan P. Indian government not doing enough to tackle sale of unapproved antibiotics. The Conversation. 13 Oct 2017.

McGettigan P, Roderick P, Kadam A, Pollock AM. Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship. The Lancet Global Health. 2017;5(11):e1075–6. download

Ofori-Asenso R, Pollock AM, Brhlikova P. Poor prescription practices across Africa are putting patients at risk. The Conversation 29 Aug 2016.

Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16:724. download

Leng HJ, Sanders D. Who is to blame for the medicines backlog? 31 Aug 2015.

McGettigan P. India: the pharmacy of the world where ‘crazy drug combinations’ go unregulated. The Conversation 20 July 2015.

Leng HJ, Mutoti KP, Mbelle N. Regulatory requirements for the development and registration of biosimilars in South Africa. GaBI Journal. 2015

Brhlikova P, Harper I, Subedi M, Bhattarai S, Rawal N, Pollock AM. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal. Globalization and Health. 2015;11(25). download

McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock, AM. Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing non-steroidal anti-inflammatory drugs (NSAIDs), metformin, or psychotropic drugs. PLoS Med. 2015;12(5):e1001826. download

Millard C, Brhlikova P, Pollock AM. Social networks and health policy: the case of misoprostol and the WHO model essential medicine list. Social Science & Medicine. 2015;132:190–6. download

Maigetter K, Pollock AM, Kadam A, Ward K, Weiss MG. Pharmacovigilance in India, Uganda and South Africa with reference to WHO’s minimum requirements. Int J Health Policy Manag. 2015;4;5:295-305. download dissemination video

Leng HJ, Sanders D, Pollock AM. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines. GaBi Journal. 2015;4(2).

Steele S, Freitag A, McGettigan P, Giovannoni G, Pollock AM. A guide to private prescribing. Prescriber. 2015 Mar 19;19–23. download

Atukunda, EC, Brhlikova P, Agaba AG, Pollock AM. Civil Society Organizations and medicines policy change: A case study of registration, procurement, distribution and use of misoprostol in Uganda. Social Science & Medicine. 2015;130:242–9. download

Evans V, Pollock AM. The proliferation of irrational metformin fixed-dose combinations in India. The Lancet Diabetes and Endocrinology. 2015;3(2):98–100. download

Magadzire BP, Budden A, Ward K, Jeffery R, Sanders D. Frontline health workers as brokers: provider perceptions, experiences and mitigating strategies to improve access to essential medicines in South Africa. BMC Health Services Research. 2014;14:520.

Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, et al. The availability of six tracer medicines in private medicine outlets in Uganda. Journal of Pharmaceutical Policy and Practice. 2014;7(18). download

Roderick P, Mahajan R, McGettigan P, Pollock AM. India should introduce a new Drugs Act. The Lancet. 2014;383(9913):203–6. download

Roderick P, Mahajan R, McGettigan P, Pollock AM, Jeffery R. Need for a new Drugs Bill. Economic and Political Weekly. Mumbai; 2014 Aug 16;15–9. download

Ward K, Sanders D, Leng H, Pollock AM. Assessing equity in the geographical distribution of community pharmacies in South Africa in preparation for a national health insurance scheme. Bulletin of the WHO. 2014;92:482–9. download

Millard C, Pollock AM, Brhlikova P. Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health. BMJ. 2014;349:g4823. download

McGettigan P, Pollock AM, Herxheimer A. MPs call for full results of all past clinical trials to be made public. BMJ. 2014 Jan 3;348(jan03 1):g13–g13.

Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. The Lancet. 2013;382(Supplement 1):10. download

Chinai R, Kadam A, Pollock AM, Jeffery R, Weiss MG, Mistry N. Access to medicines under India’s National Disease Control Programmes: local study of TB, HIV and malaria medicines. AMASA; 2013.

Chinai R, Kadam A, Mahajan R, Pollock AM, Jeffery R, Maigetter K, et al. Inadequately enforced workforce planning norms undermine safety of Indian drugs. AMASA; 2013.

Chinai R, Kadam A, Mahajan R, McGettigan P, Pollock AM, Jeffery R, et al. ‘Fixed Dose Combination’ drugs and the case of Metformin. AMASA; 2013.

Chu CS, Brhlikova P, Pollock AM. Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage. JRSM. 2012;105:336–47. download

Mattheij I, Pollock A, Brhlikova P. Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness. JRSM 2012;105:250–62. download

Pollock AM, Brhlikova P, Mattheij I. Author’s Response: HPV vaccination in India. JRSM 2012;105:366–7. download

Pollock A, Brhlikova P, McGettigan P. Reviewer’s commentary on ‘Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence’. BJOG : an international journal of obstetrics and gynaecology 2012;:11. download

Roderick P, Pollock A. India’s patent laws under pressure. The Lancet 2012;380:e2–e4. download

Richardson E, Pollock A. Community pharmacy: moving from dispensing to diagnosis and treatment. BMJ 2010;340:c2298. download

Pollock AM, Price D. Briefing on the specification of pharmaceutical product defects. Centre for International Public Health Policy 2009. download

Pollock AM, Kerrison S, McNally N. Best research. BMJ 2006;332:247–8. download

Kerrison S, Pollock AM. The reform of UK research ethics committees: throwing the baby out with the bath water? Journal of Medical Ethics 2005;31:487–9. download

Kerrison S, McNally N, Pollock AM. United Kingdom research governance strategy: Authors’ reply. BMJ 2004;328:50–50. download

Kerrison S, McNally N, Pollock A. United Kingdom research governance strategy. BMJ 2003;327:553–6. download

McNally N, Kerrison S, Pollock A. Reforming clinical research and development in England. BMJ 2003;327:550–3. download